Have you registered? Don't miss your chance to catch @DrBonillaOnc's presentation at the Virtual Pharma R&D conference today at 1:20 PST / 4:20 EST. Register here: bit.ly/3bzfe9Y

Kudos to the Vidence team as we present at Pharma R&D 2021 one of many our SCIMON #RWE Dashboards, powered by AI and top-of-the-line oncology data! #ai #oncology #vidence #PharmaceuticalsBiotech

Healthcare data can change the world. Lead AI Advisor to the UN sheds light on the applications of this technology for the betterment of the world – and how the UN is utilizing global data sources to find solutions to various illnesses, in InformationWeek bit.ly/3aJvMNd

A new deep learning model proved 71% effective in determining the survival expectancy of patients living with lung cancer – helping clinicians to make better-informed treatment decisions moving forward. Read more in .: bit.ly/2ZJt4kA

The American Cancer Society 2021 Cancer Fact & Figures Report found this past year was the largest single-year decline in cancer's mortality rate – but as many avoided routine screenings during COVID-19, its impact on cancer isn't yet determined. Full report here: bit.ly/3p4vxQZ

From early diagnosis to personalized treatments and aid in drug development, AI can help treat cancer in a variety of ways and on a global scale – and even help to eliminate healthcare discrepancies across the globe. More in World Economic Forum: bit.ly/3e4nsdg

Patient data and AI can help inform clinical decision making – but these datasets are often incomplete and lack information around patient outcomes, which is why Vidence's oncology-focused solutions are built with direct input from end users. More in The Wall Street Journal: on.wsj.com/2NVAu1V

With the help of data analytics and large genomic datasets, a recent study found that emerging technologies can be utilized to examine shared features between various cancer types to ultimately improve cancer drug development. More in .: bit.ly/38443oG

AI tools can diagnose diseases as well as humans – and even dogs. A recent study found that an AI-powered system proved as effective at detecting prostate cancer as dogs, but can also promise more consistency with regular use. More in Scientific American: bit.ly/3rthPci

The genomic and big data revolutions are in full force – but as technology continues to evolve, their benefits for patients will reshape approaches to medicine. Read more about the benefits of AI tools and the outlook of cancer care by 2030 in OncLive.com: bit.ly/3bw743B

The pandemic fueled AI adoption in healthcare. In fact, a recent study from KPMG found that 82% of healthcare executives want to see their organizations more aggressively adopt AI, and 62% say AI is already providing them value. More in FierceHealthcare: bit.ly/2OGTIrW

Great discussion about #AI, #decentralized #clinicaltrials and #digitalhealth at Clinical Trials in Precision Medicine Conference precisionmedicineleaderssummit.com/clinical-trial…

Precision medicine helps to match patients with specific treatment options that are best suited for each individual – and these targeted therapies are reshaping breast cancer research and our approach to treatments as a whole. Read more in @cure_magazine: bit.ly/3llZlYU

From predicting hospital admission outcomes to advanced breast cancer profiling, explore recent and groundbreaking studies around the use cases of AI in healthcare in Becker's Hospital Review – and learn more about Vidence's AI Initiatives on our website: bit.ly/3eNb2XA

Through our proprietary technology platform SCIMON, Vidence Consortium Fellows are better positioned to improve their internal data capabilities and increase the number of clinical trials available to patients. Learn more: bit.ly/3shwHuS

According to a new report, AI investments in healthcare increased significantly in 2020 at a total of $13.8 billion, with areas like drugs, cancer and drug discovery accounting for most of these dollars. More in @ZDNet: zd.net/3rhcL9U

Vidence’s professional tools and services can help accelerate active product and drug development, clinical studies and treatment planning. Explore our offerings in key areas like precision medicine and data visualization on our website: bit.ly/395InJu

Our proprietary technology platform, SCIMON, holds the electronic health records (EHR) and other operational data for over 100,000 patients – helping organizations to derive meaningful clinical insights. Learn more: bit.ly/3dqhzF1

Researchers developed an AI tool that uses heatmaps to show how the technology made its clinical decision recommendations – driving visibility into these tools and helping medical providers to better understand their conclusions. More in MobiHealthNews: bit.ly/3rG0CeQ

Want the latest updates from Vidence sent directly to your inbox? Stay up to date by signing up for our newsletter to receive relevant industry news, events and announcements from our team: vidence.com